0000874015-24-000005.txt : 20240102 0000874015-24-000005.hdr.sgml : 20240102 20240102175431 ACCESSION NUMBER: 0000874015-24-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOUGEN ELIZABETH L CENTRAL INDEX KEY: 0001074773 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 24503748 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT STREET 2: C/O IONIS PHARMACEUTICALS, INC. CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-12-28 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001074773 HOUGEN ELIZABETH L 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP, Finance & CFO 0 Common Stock 2023-12-28 4 M 0 45225 47.34 A 120884 D Common Stock 2023-12-28 4 F 0 43798 50.5 D 77086 D Non-Qualified Stock Option (right to buy) 47.34 2023-12-28 4 M 0 45225 0.0 D 2021-01-03 2024-01-02 Common Stock 45225 0 D Represents a "net exercise" of outstanding stock options. The reporting person received 1,427 shares of common stock on net exercise of option to purchase 45,225 shares of common stock. Pursuant to the terms of the Company's 2011 Equity Incentive Plan, the Company withheld 43,798 shares of common stock underlying the option for payment of the exercise price and tax withholdings using the closing stock price on December 28, 2023 of $50.50. By: Patrick R. O'Neil, attorney-in-fact For: Elizabeth L. Hougen 2024-01-02